Edition:
United Kingdom

People: Bruker Corp (BRKR.OQ)

BRKR.OQ on NASDAQ Stock Exchange Global Select Market

48.35USD
19 Jul 2019
Change (% chg)

-- (--)
Prev Close
$48.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
289,330
52-wk High
$51.35
52-wk Low
$26.11

Herman, Gerald 

Mr. Gerald N. Herman is Chief Financial Officer Officer of the Company. Mr. Herman has served as our Chief Financial Officer since June 2018, after being named Interim Chief Financial Officer in March 2018. Mr. Herman joined Bruker in 2016 as Vice President and Corporate Controller. Prior to joining Bruker, Mr. Herman had served in senior executive positions with various publicly traded companies, including as Corporate Vice President—Clinical Operations of PAREXEL International from 2014 to February 2016, and as Corporate Vice President & Controller-Finance of PAREXEL from 2008 to 2013. Prior to 2008, Mr. Herman was Vice President—Corporate Controller of Presstek, Inc. He also served in financial, consulting and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr. Herman is a Certified Public Accountant (CPA) and holds a Master of Business Administration degree from the University of Chicago, and a Master of Science in Taxation from Bentley University.

Basic Compensation

Total Annual Compensation, USD 360,939
Restricted Stock Award, USD 352,515
Long-Term Incentive Plans, USD --
All Other, USD 313,067
Fiscal Year Total, USD 1,026,520

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Frank Laukien

4,479,900

Gerald Herman

1,026,520

Falko Busse

699,245

Burkhard Prause

967,913

Juergen Srega

1,390,790

Mark Munch

1,820,810
As Of  31 Dec 2018